Abstract
Synthetic polyesters, such as polylactides and polyglycolides and their copolymers, have found a wide range of applications in the biomedical field thanks to their biocompatibility and biodegradability.1, 2 In particular, polylactides, derived from lactic acid, degrade in the human body via a hydrolytic reaction. This reaction produces first oligomers and then lactic acids, of which the L-lactic acid is a natural intermediate in carbohydrate metabolism. The monomer unit of polylactide, shown in Fig. 1 , includes a chiral carbon. The mechanical properties of such a polymer depend on its stereoregularity. Optically pure poly(L-lactide) (PLLA) and poly(D-lactide) (PDLA) are semicrystalline materials, while poly(D,L-lactide) (PDLLA), consisting of racemic lactate units, is amorphous. Although the mechanical properties of PLLA and PDLA are superior with respect to PDLLA, those polymers are brittle at room temperature.3 Moreover, the degree of crystallinity of polylactides influences their degradation rate in biological fluids, i.e., amorphous PDLLA exhibits the highest degradation rate. Due to its relative high rate of degradation, and the absence of late foreign body reactions due to crystalline remnants,4 PDLLA has been extensively studied for in-vivo biomedical applications, such as osteosynthesis temporary implant materials4 and composite scaffolds,5 controlled release of drugs,6 proteins and antigens,7 resorbable sutures,8 and lately as coating for improving mechanical properties of brittle bioactive glass scaffolds for bone tissue engineering.9

This publication has 29 references indexed in Scilit: